APA (7th ed.) Citation

CA, H., MR, S., H, A., EE, J., L, R., R, P., . . . GR, S. (2017). Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies. JACC. Clinical electrophysiology, 3(10), 1158. https://doi.org/10.1016/j.jacep.2017.02.016

Chicago Style (17th ed.) Citation

CA, Henrikson, et al. "Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator And Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies." JACC. Clinical Electrophysiology 3, no. 10 (2017): 1158. https://doi.org/10.1016/j.jacep.2017.02.016.

MLA (9th ed.) Citation

CA, Henrikson, et al. "Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator And Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies." JACC. Clinical Electrophysiology, vol. 3, no. 10, 2017, p. 1158, https://doi.org/10.1016/j.jacep.2017.02.016.